Evidence has demonstrated that PHGDH has additional enzymatic activity by converting NADH-dependent reduction of α-KG to the oncometabolite D-2-hydroxyglutarate (D-2HG) in breast cancer 49, 50. The gene discussed is PHGDH; the disease is breast cancer.